Bayer, J&J tout rivaroxaban data
This is a discussion on Bayer, J&J tout rivaroxaban data within the Biotechnology News forum, part of the Industry News and Updates category; In a head-to-head study against Sanofi's Lovenox, Bayer and J&J's oral anti-clotting drug ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
06-01-2008, 01:55 PM
|
|||
|
|||
Bayer, J&J tout rivaroxaban data
In a head-to-head study against Sanofi's Lovenox, Bayer and J&J's oral anti-clotting drug rivaroxaban proved superior in preventing venous blood clots in patients who underwent total knee Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Bayer and FDA inform healthcare professionals of the market withdrawal of the current | industry_news | FDA News | 0 | 02-26-2008 03:30 PM |
© 2008 DrugManagementForum™ powered by |
 |